コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 etoxifying enzyme, aldehyde dehydrogenase 2 (ALDH2).
2 c nucleophile, Cys243, in ALDH3A1 but not in ALDH2.
3 at aortic rings and the function of purified ALDH2.
4 of organic nitrates to the catalytic site of ALDH2.
5 oactivation of GTN is catalyzed by cytosolic ALDH2.
6 tasis, the effect of which was alleviated by ALDH2.
7 d provides a lead for the design of improved ALDH2.
8 reases the K(m) for NAD(+), as compared with ALDH2.
9 amination of deposited electron densities of ALDH2.
10 nced deacylation, the rate-limiting step for ALDH2.
11 on each individual kinetic step of ALDH1 and ALDH2.
12 1.16 +/- 0.56, and 0.40 +/- 0.10 microM for ALDH2.
13 found to be heterozygous when genotyped for ALDH2.
14 are associated with increased expression of ALDH2.
15 in diabetic mouse heart which was rescued by ALDH2.
16 e-binding site of the free enzyme species of ALDH2.
17 lial cells infected with wild-type or mutant ALDH2.
18 cal significance of NO formation by purified ALDH2.
19 heast Asia that are genetically deficient in ALDH2.
20 ALDH2 protein in HeLa cell lines expressing ALDH2*1, ALDH2*2, or both were determined by the rate of
23 tly, we have solved the crystal structure of ALDH2(*)2 complexed with coenzyme to 2.5A(.) We have als
26 helix within the coenzyme binding pocket of ALDH2(*)2 is reordered, but the active site is only part
27 mitochondrial aldehyde dehydrogenase (ALDH2) ALDH2(*)2 polymorphism is associated with impaired ethan
33 tion showed that human participants carrying ALDH2*2 exhibited impaired vasodilation after light alco
36 t on the enzyme activity, we now report that ALDH2*2 heterozygotes had lower levels of ALDH2 immunore
41 association study (GWAS) from Biobank Japan, ALDH2*2 was found to be one of the strongest single-nucl
42 ontrast to the missense variant ALDH2 rs671 (ALDH2*2), which is common only in East Asian populations
43 -1 was a particularly effective activator of ALDH2*2, an inactive mutant form of the enzyme that is f
45 otein in HeLa cell lines expressing ALDH2*1, ALDH2*2, or both were determined by the rate of loss of
53 liver mitochondrial aldehyde dehydrogenase (ALDH2-2), present in some Asian populations, lowers or a
54 vered highly ordered filament arrays of Ald4(ALDH2), a conserved aldehyde dehydrogenase that is highl
56 ncy in mitochondrial aldehyde dehydrogenase (ALDH2), a tetrameric enzyme, results from inheriting one
58 clude signals in or near GDAP1, PTF1A, SIX3, ALDH2, a microRNA cluster, and genes that affect the dif
59 enes across different trait pairs, including ALDH2, ACAD10, TMEM116, SH2B3 (all at 12q24.12), TMED6 (
61 eceptors, which triggers PKCepsilon-mediated ALDH2 activation in cardiac mast cells, contributing to
63 cardiac 4-HNE levels through pharmacological ALDH2 activation is sufficient to re-establish Dicer act
67 ion in liver ALDH2 mRNA, a 40% inhibition in ALDH2 activity, and a fourfold (P < 0.001) increase in c
74 screen yielded a small-molecule activator of ALDH2 (Alda-1) that, when administered to rats before an
75 common mitochondrial aldehyde dehydrogenase (ALDH2) ALDH2(*)2 polymorphism is associated with impaire
76 problems associated with mutations of ALDH1, ALDH2, ALDH4, ALDH10 and succinic semialdehyde (SSDH) ge
77 mitochondrial aldehyde dehydrogenase type-2 (ALDH2) also mimicked and prevented, respectively, the ca
78 in alcohol metabolizing genes, for example, ALDH2 and ADH1B, are strongly associated with alcohol co
79 w that formaldehyde is a common substrate of ALDH2 and ADH5 and establish methods to quantify elevate
80 res protection by the detoxification enzymes ALDH2 and ADH5 and the Fanconi anemia (FA) DNA repair pa
81 ingle nucleotide polymorphism (SNP) rs671 in ALDH2 and alcohol drinker status (odd ratio (OR)=0.40, P
82 s encoding cytosolic ALDH1 and mitochondrial ALDH2 and ALDH5 were disrupted in the genome of strain T
83 activity and immunoblot results showed that ALDH2 and ATP synthase were also inhibited through oxida
85 our psoralen and coumarin derivatives toward ALDH2 and compared them to the ALDH2 inhibitor daidzin f
87 aldehyde detoxifying enzymes, mitochondrial ALDH2 and cytoplasmic ADH5, have greatly shortened lifes
88 Consistent with our high-level calculations, ALDH2 and GAPDH, enzymes implicated in nitroglycerin bio
89 e the potency and selectivity for ALDH1A1 or ALDH2 and generate chemical probes to examine the unique
91 ree-dimensional structures of wild-type (WT) ALDH2 and of a triple mutant of the protein that exhibit
92 stimation (utilizing interaction of rs671 in ALDH2 and sex as an instrument) strengthens causal infer
94 de clearance through ALDH2 by using global- (Aldh2 (-/-)) and tissue-specific Aldh2-deficient mice, a
95 dehyde dehydrogenase 2 (a protein encoded by ALDH2) and Glu4Gly of BRCA1-associated protein (a protei
98 otes and six (GCKR, ADH1B, ALDH1B1, ALDH1A1, ALDH2, and GOT2) in heterozygotes, with five showing gen
99 (CASZ1, MOV10, FGF5, CYP17A1, SOX6, ATP2B1, ALDH2, and JAG1) at genome-wide significance, and 6 (FIG
100 ated that DPI binds to the catalytic site of ALDH2, and this was confirmed by experiments showing sub
101 fic missense variant, rs671 (p.Glu457Lys) of ALDH2, and two traits including aspartate aminotransfera
102 tabolism, and ion channels, including SPTA1, ALDH2, ANK1, HK1, MAPKAPK5, AQP1, PIEZO1, and SLC4A1/ban
103 LPL, MYB, NXPH1, PER2, TNFA), gene-alcohol (ALDH2, APOA5, APOC3, CETP, LPL), gene-smoking (APOC3, CY
104 the gene encoding aldehyde dehydrogenase 2 (ALDH2) are at increased risk of cardiovascular disease (
107 fied mitochondrial aldehyde dehydrogenase 2 (ALDH2) as an enzyme whose activation correlates with red
108 ysis with the aldehyde dehydrogenase 2 gene (ALDH2) as an instrumental variable to examine the associ
109 The inhibition of ALDH1 and activation of ALDH2 at pH 7.4 are due to their different rate-limiting
110 lude mitochondrial aldehyde dehydrogenase 2 (ALDH2), ATP synthase, acyl-CoA dehydrogenase, 3-ketoacyl
112 ther study is needed to clarify the roles of ALDH2, BRAP and CUX2 in the liver-brain endocrine axis c
114 ent organs in acetaldehyde clearance through ALDH2 by using global- (Aldh2 (-/-)) and tissue-specific
115 , acetaldehyde-catabolism-competent mothers (Aldh2(+/-)) can support the development of double-mutant
116 ve previously shown that a minor reaction of ALDH2-catalyzed GTN bioconversion, accounting for about
121 r isolated aortas with adenovirus containing ALDH2 cDNA with or without the mitochondrial signal pept
123 SA, GCKR, AGR3-AHR, ADH1B, ALDH1B1, ALDH1A1, ALDH2, CYP1A2-CSK and ADORA2A-AS1) for 13 dietary traits
124 ion approach to correct for this bias in our ALDH2 data and, also, to explore the effect of bias on t
128 lar localization of ALDH2 using immortalized ALDH2-deficient aortic smooth muscle cells and mouse aor
129 Overexpression of ALDH2 in the cytosol of ALDH2-deficient aortic smooth muscle cells led to a sign
131 dent from causing hepatocyte death, and that ALDH2-deficient individuals may be resistant to steatosi
132 ng global- (Aldh2 (-/-)) and tissue-specific Aldh2-deficient mice, and to examine whether liver-speci
133 e ethanol intoxication in both wild-type and ALDH2-deficient, ALDH2*1/*2, heterozygotic knock-in mice
136 nce that the pattern of genetic variation at ALDH2 differs from that expected under a standard neutra
137 t Asian-specific missense variant (rs671) in ALDH2 displayed a significant association on chromosome
138 ts suggest that transgenic overexpression of ALDH2 effectively antagonizes chronic alcohol intake-eli
139 s missense variant leads to a severe loss of ALDH2 enzymatic activity and has been linked to an incre
142 ded subunit (ALDH2K) reduces the activity of ALDH2 enzyme in cell lines expressing the wild-type subu
143 ncy allele for the aldehyde dehydrogenase 2 (ALDH2) enzyme, a critical protein involved in the metabo
145 ose from restriction enzyme digestion of the ALDH2 exon 12 functional polymorphism (Glu-487-Lys) in 1
148 uman and mouse kidneys and demonstrated that ALDH2 expression was significantly reduced, and that the
151 the p53 response is vigorously activated in Aldh2(-/-)Fancd2(-/-) HSCs, while p53 deletion rescued t
155 nd not more mature blood precursors, require Aldh2 for protection against acetaldehyde toxicity.
156 glucose) and identified several cis-eGenes (ALDH2 for systolic and diastolic blood pressure, MCM6 an
157 taldehyde metabolism, a cumulative effect of ALDH2 from other organs likely also contributes to syste
158 we treated ALDH2*2 knock-in mice, a loss of ALDH2 function model, with aristolochic acid and found t
159 tely 40-50% of East Asians carry an inactive ALDH2 gene and exhibit acetaldehyde accumulation after a
163 We also found that several ADH genes and the ALDH2 gene were susceptibility loci for AD, and the asso
165 ADH6, and ADH7 genes), 4 markers within the ALDH2 gene, and 38 unlinked ancestry-informative markers
166 d reductions in ALDH2 mRNA levels of 85% and ALDH2 (half-life of 22 h) activity of 55% equivalent to
170 mes from ethanol-containing bottles, whereas Aldh2 (Hep-/-) mice showed reduced alcohol preference at
171 evels in hepatocyte-specific Aldh2 knockout (Aldh2 (Hep-/-)) mice were significantly higher than thos
173 at ALDH2*2 heterozygotes had lower levels of ALDH2 immunoreactive protein in autopsy liver samples.
177 ovide new evidence for the essential role of ALDH2 in GTN bioactivation and may have implications to
178 This data indicates a potential key role of ALDH2 in influencing acrolein levels, oxidative stress,
179 , we characterized the expression pattern of ALDH2 in normal and CKD human and mouse kidneys and demo
182 Several SNPs that function as eQTLs for ALDH2 in various tissues showed evidence of strong posit
183 of the function of aldehyde dehydrogenase 2 (ALDH2) in EAE mice using either a pharmacological or gen
184 flanking the aldehyde dehydrogenase 2 locus, ALDH2, in populations of Japanese alcoholics and control
185 one or two copies of the G allele in rs671 (ALDH2) increased the risk of excessive alcohol consumpti
188 mice, and to examine whether liver-specific ALDH2 inhibition can prevent alcohol-seeking behavior.
189 atives toward ALDH2 and compared them to the ALDH2 inhibitor daidzin for selectivity against five ALD
197 ow that the acetaldehyde-catabolising enzyme Aldh2 is essential for the development of Fancd2(-/-) em
198 Quantitative Western blotting revealed that ALDH2 is mainly cytosolic in mouse aorta and human coron
206 n against ALDH1A1 over ALDH3A1, ALDH1B1, and ALDH2 isozymes as well as other dehydrogenases such as H
207 uding compound 36, a selective inhibitor for ALDH2 (Ki = 2.4 muM), and compound 32, which was 10-fold
208 es of the brown adipose tissue from the male Aldh2 knock-in mice identifies increased 4-hydroxynonena
210 both Aldh2-knockout mouse keratinocytes and ALDH2-knockdown human keratinocytes treated with acetald
211 Acetaldehyde levels in hepatocyte-specific Aldh2 knockout (Aldh2 (Hep-/-)) mice were significantly
212 inactivation of aldehyde catabolism (through Aldh2 knockout) and the Fanconi anaemia DNA-repair pathw
213 xyguanosine were higher in the oesophagus of Aldh2-knockout mice than in wild-type mice upon ethanol
214 e-2'-deoxyguanosine levels increased in both Aldh2-knockout mouse keratinocytes and ALDH2-knockdown h
215 context, interventions capable of increasing ALDH2 levels and/or activity are considered promising th
216 m) and mitochondrial aldehyde dehydrogenase (ALDH2, low Km) in Escherichia coli and purified the enzy
219 paradigm and the drinking-in-the-dark model, Aldh2 (-/-) mice drank negligible volumes from ethanol-c
221 e and motility were dramatically dampened in Aldh2 (-/-) mice, but moderately decreased in Aldh2 (Hep
223 anol-treated precision-cut liver slices from ALDH2(-/-) mice and in Kupffer cells isolated from ethan
225 Compared with wild-type mice, ethanol-fed ALDH2(-/-) mice had higher levels of malondialdehyde-ace
227 d in Kupffer cells isolated from ethanol-fed ALDH2(-/-) mice than those levels in wild-type mice.
231 oligonucleotide (ASO-9) showed reductions in ALDH2 mRNA levels of 85% and ALDH2 (half-life of 22 h) a
233 to rats resulted in a 50% reduction in liver ALDH2 mRNA, a 40% inhibition in ALDH2 activity, and a fo
234 lar smooth muscle cells (VSMC) expressing an ALDH2 mutant that reduces GTN to NO but lacks clearance-
235 r the KCNQ1 (rs2237892, P = 9.29 x 10(-13)), ALDH2/MYL2 (rs671, P = 3.40 x 10(-11); rs12229654, P = 4
238 some 4) and one aldehyde dehydrogenase gene (ALDH2 on chromosome 12) exhibit functional polymorphisms
239 prior studies reported effects of ADH1B and ALDH2 on lifetime measures, such as risk of alcohol depe
240 overexpression of aldehyde dehydrogenase-2 (ALDH2) on chronic alcohol ingestion-induced myocardial d
242 udies published in the last decade show that ALDH2 overexpression downregulates atrophic genes; meanw
245 which is due to an alcohol dehydrogenase 2 (ALDH2) polymorphism that leads to impaired alcohol metab
246 sociations exist between the ADH2, ADH3, and ALDH2 polymorphisms and alcohol dependence in a group of
248 periments revealed that acetaldehyde induced ALDH2 production in both mouse and human oesophageal ker
249 e, we report that ethanol drinking increased ALDH2 production in the oesophagus of wild-type mice.
250 decreased transcriptional activity from the ALDH2 promoter approximately 50% in reporter gene assays
251 lete linkage disequilibrium with the derived ALDH2 promoter variant rs886205, which is associated wit
253 orm of mitochondrial aldehyde dehydrogenase (ALDH2) protects nearly all carriers of this gene from al
257 d aldehyde adducts, and that an activator of ALDH2 reduced I/R injury in males but had no significant
259 tructures of the triple mutant and wild-type ALDH2 reflect binding of GTN to the catalytic site and t
260 and may have implications to other fields of ALDH2 research, such as hepatic ethanol metabolism and c
263 C expressing either wild-type or C301S/C303S ALDH2 resulted in pronounced intracellular NO elevation,
265 s pathway may explain how subjects harboring ALDH2 rs671 are at a greater risk for numerous other dis
266 xperiments that reveal a pathway wherein the ALDH2 rs671 mutant is phosphorylated by AMPK and translo
267 pecific variant on aldehyde dehydrogenase 2 (ALDH2 rs671, G>A) is the major genetic determinant of al
268 results were maintained when controlling for ALDH2 (rs671) and ADH1B (rs1229984) markers and when exa
272 ng to have a structure very similar to human ALDH2, scallop Omega-crystallin was enzymatically inacti
280 gate the causes of linkage disequilibrium in ALDH2, the gene that encodes aldehyde dehydrogenase 2.
281 cigarettes per day (EPHX2-CLU, RET and CUX2-ALDH2), three loci associated with smoking initiation (D
282 liver mitochondrial aldehyde dehydrogenase (ALDH2) to change from deacylation to hydride transfer.
284 Nasal polyp ALDH2 protein and nasal EpC ALDH2 transcripts were lower in AERD patients than in as
287 affected by the subcellular localization of ALDH2 using immortalized ALDH2-deficient aortic smooth m
288 n of mitochondrial aldehyde dehydrogenase 2 (ALDH2) using Alda-1 or its improved orally bioavailable
292 es and diplotypes of ADH1A, ADH1B, ADH7, and ALDH2 were associated with AD in European Americans and/
294 the esterase and dehydrogenase activities of ALDH2 were inhibited to the same extent by MeDTC sulfone
295 overed loci, four (GCKR, ADH1B, ALDH1A1, and ALDH2) were suggested to interact with rs671 in the risk
297 useful for patients with wild-type or mutant ALDH2 who are subjected to cardiac ischemia, such as dur
299 leles at the CHRNA3-CHRNA5 locus, ADH1B, and ALDH2 with respect to phenotypic traits related to anthr
300 ociations of genetic variants (e.g. rs671 in ALDH2) with such risk factors in women - who drank littl
301 human mitochondrial aldehyde dehydrogenase (ALDH2) yielded an unexpected result: the chemically reas